News
Industry News
LY News
Certifications
Latest News

A Brief Introduction To Reusable Incontinence Pad

The incontinence pad ensures a healthy, comfortable sleep, protected by moisture, and reliable. The pad is formed by five different layers, making th...

The Difference Between Medical Non-woven fabrics and Ordinary Non-woven

The packaging part is an important part of the daily work in the disinfection supply center. The purpose of the packaging is to establish an aseptic b...
Contact Us
H.K LanYuan Protective(Wuhan)Co.,Limited
Add: Unit101,D403,LinYun Industrial Zone,JinShan Avenue,DongXiHu Area of Wuhan China
Cell Phone: 86 18062501536
Tel: +86 27 8373 4835
Fax: +86 27 8373 4835
Contact Person: Mrs Milan Zhang
Email: milan@lanyuansupply.com
       milan988@gmail.com Contact Now

Hot Products
News
Your position : Home > News > Industry News > AGC develops nonmedical ...

AGC develops nonmedical repellent fabrics with "improved environmental and biological profiles&

http://www.nonwovens.com/ 2016-06-27 14:06:16

medical products such as surgical gowns, Masks, curtains and packaging must be able to repel liquids, oil and alcohol, and quickly release stains when washed. These properties are achieved by coating nonwoven fabrics repelling agents before they are made into clothing. However, repelling agents have had a history of sustainability issues because of their potential to break the formation of perfluorooctanoic acid (PFOA). To address this problem, AGC Chemicals Americas AG-E600 AsahiGuard developed, high performance, free of repellent PFOA * with better environmental and biological profiles.

AG-E600 repelling agents have been evaluated by industry regulators and considered safe and effective for use in Medical nonwovens. They are based on patented AGC-C6 short chain polymerization, which is non-toxic technology and is not broken down to form PFOA and perfluorooctane sulfonate (PFOS). Furthermore, AG-E600 is alkylphenol ethoxylate (APEO) and contains free acids in length longer chain (perfluorocarboxylic PFCA) or their precursors. *